HealthEquity (HQY) Director Wellborn Furgurson Receives RSU Award

What Happened

• Wellborn Gayle Furgurson, a director of HealthEquity, Inc. (HQY), received a grant of 2,877 restricted stock units (RSUs) on June 25, 2026. The Form 4 reports the acquisition at $0.00 per unit (an award/grant rather than a purchase).
• This transaction is an equity award (code A) representing contingent rights to shares; it is not a sale or open-market purchase.

Key Details

• Transaction date: 2026-06-25; Form 4 filed: 2026-06-29.
• Shares/units granted: 2,877 RSUs; reported price: $0.00 (award).
• Shares owned after transaction: not specified in the filing.
• Footnote: Each RSU equals a contingent right to one common share. Vesting occurs on the earlier of (i) June 25, 2027 or (ii) the issuer’s next annual stockholder meeting in June 2027; vested shares will be delivered upon vesting.
• Remarks: A previously filed power of attorney (filed June 26, 2023) is incorporated by reference.

Context

• RSU grants are a form of compensation for directors; the $0.00 price reflects an award rather than a cash purchase. The units convert to shares only upon vesting per the schedule above.
• Such awards are routine for executives and directors and do not, by themselves, indicate trading intent or immediate market activity.